20
Apr
Mon
in-person
Artificial Intelligence and Diagnostic Inventions: Significant shifts in the Examination of Patent-Eligible Subject Matter, John Morgan, Seed IP Law Group
The emergence of artificial intelligence (AI) systems offers paradigm-shifting advances in many areas of human endeavor, including healthcare. Yet, innovations in AI and diagnostic medicine have met significant patent-eligibility hurdles in recent years. Innovators will therefore be interested in recent, patent-friendly changes in US Patent Office policy and proposed legislation to reform US patent law regarding subject-matter eligibility, and to adapt their patent practice and strategy accordingly to benefit business needs.
This topic covers:
a brief introductory history of US patent-eligible subject matter examination and case law
recent changes in USPTO policy and proposed legislative reform
adapting patent practice and strategy to benefit business needs, including identifying patent-eligible inventions, IP cost allocation and control, portfolio management, and consistency in approach across the portfolio and multiple jurisdictions
Speaker
“
John Morgan
Partner. Seed IP Law Group.
Passionate about the confluence of science, business, and law, John advises biotechnology companies, investors, and research entities on intellectual property matters. Representative subject matter includes large molecules (e.g., antibodies, fusion proteins, oligonucleotide therapies, vaccines), diagnostics, cell and gene therapies, biologics manufacturing, and engineered microorganisms. John is particularly interested in the application of artificial intelligence systems to drug design.
John aligns intellectual property strategies with his clients’ business and technology objectives, applying his natural curiosity, attention to detail, and creativity to patent counseling and strategy (often from benchtop to clinic and beyond), prosecution, landscape and freedom-to-operate analysis, and due diligence. Prior to becoming an attorney, John conducted research at Fred Hutchinson Cancer Center in Seattle, studying cell signaling and tissue patterning in a vertebrate brain model, as well as cell growth genes in an invertebrate model. John received his J.D. summa cum laude from Seattle University School of Law (2014) and his B.S. from the University of Puget Sound.
01
all founders,
not just ceo
People inclined to be Founders are a rare breed, and are hard to spot in society. We welcome ALL Founders, regardless of role, and generate proprietary profiles for every member so you can easily find your next team member or co-Founder.
02
current founders
Regardless of where you are on your journey, Founders share a unique set of challenges. Hiring, leadership, managing investors, developing products, handling customer issues, external communications, etc. This community exists to amplify your success.
03
TRANSITIONING FOUNDERS
So you’ve founded at least one company, and now you’re looking to refine your next great idea or find the perfect co-founder. Share and learn from a wide array of talented Founders in your area.
04
CURIOUS FOUNDERS
Congratulations! You’ve found success as a Founder and are now getting curious about doing it again. Now you need to find the right idea and co-founder to excite you. Share your wisdom and passion while forming new bonds within the startup ecosystem in your area.
To Pre-Qualify for participation, please fill out an application
Apply Now